Solid Biosciences Inc.
NASDAQSolid Biosciences reports today with short sellers holding their largest position in months — yet the options market and analyst community point firmly the other way. Short interest is the defining tension heading into this print. Bears have added aggressively through July: the short position has climbed 26.4% in a single week and 31.3% over the past month, reaching 26.5% of the…
SLDB short interest surges 26% in one week to 26.5% of free float, highest level in recent window, as bears pile in ahead of August 12 earnings despite abundant borrow availability at 227% and minimal cost to borrow.
Solid Biosciences reports today with short sellers holding their largest position in months — yet the options market and analyst community point firmly the other way. Short interest is the defining tension heading into…
Solid Biosciences heads into its August 12 earnings print with short sellers rebuilding aggressively — yet the stock is up on the week, creating the week's central tension. Short interest has become the defining story…
Snapshot as of 2 Sept 2026
Solid Biosciences heads into mid-June with a notable split: short sellers are quietly adding to already-elevated positions, while every analyst covering the stock maintains a bullish rating and targets that sit well…
Solid Biosciences heads into its June 10 earnings report with an unusual split: short interest climbing while the Street grows more bullish. The earnings event is the lens through which everything else reads this week.…
Solid Biosciences heads into its May 19 quarterly report with shorts retreating from a recent peak yet the stock still carrying one of the more elevated short positions in the gene therapy space. Short sellers have…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLDB — free to start on ORTEX.
Sign up for free →Open SLDB on ORTEX